The Evolution of Immunotherapy Against Tumors

An Historical Approach

By:

Domenico Ribatti

Format:

Paperback / softback

$338.99

Releases 1 Sep 2024

Available for pre-order now

0 in Trolley

Price Match

Buy Now, Pay Later with:

4 payments of $84.75 with Afterpay Learn more

Pre-order Price Guarantee

If Mighty Ape's price changes before release, you'll pay the lowest price.

Availability

This product will be released on 1st September, 2024

Delivering to:

It should arrive:

6-13 September using International Courier

Description

The Evolution of Immunotherapy Against Tumors: An Historical Approach summarizes the literature concerning the development of the theory of immune surveillance against tumors. It discusses the evidence for and against this theory, along with the concept of immunoediting. Finally, current approaches in anti-tumor immunotherapy will be analyzed. The immune system plays a major role in the surveillance against tumors. To avoid attack from the immune system, tumor cells develop different strategies to escape immune surveillance. Evidence of immune surveillance comes from both animal models and clinical observations. Mice with a wide variety of immunodeficiencies have a high rate of tumor incidence and are more susceptible to transplanted or chemical carcinogen-induced tumors. Immunosuppressed patients have a high incidence of tumors. However, many patients develop cancer even in the presence of an apparently normal immune system. This indicates that tumor cells can escape immune surveillance.

Author Biography:

Domenico Ribatti was awarded his M.D. degree in October 1981, with full marks. In 1983, D.R. joined the Medical School as Assistant at the Institute of Human Anatomy, University of Bari. In 1984, he took the specialization in Allergology. In 1989, he spent one year in Geneva, working at the Department of Morphology (Prof. R. Montesano). In 2008, he received the honoris causa degree in Medicine and Pharmacy form the University of Timisoara (Romania). D.R. is author of 866 publications as reported in PUBmed and contributed to 50 chapters to books. Overall, his papers have been cited 51153 times. He has published many books with both Elsevier and Springe

Release date Australia

September 1st, 2024

Author